September 2018	First presentation. Newly diagnosed moderate pericardial and pleural effusion. Transthoracic echocardiogram is suggestive of effusive constrictive disease. Pleural aspirate Mycobacterial tuberculosis (TB) polymerase chain reaction (PCR) positive. Commenced on standard anti-TB therapy and prednisone.
October 2018	Discharged from hospital, however, rapid progression to New York Heart Association class III symptoms.
November 2018–January 2019	Readmission with bilateral pleural effusions. Pleural biopsy TB PCR positive. Refractory pleural effusions with prolonged drain requirements.
January 2019	Simultaneous left and right heart catheterization consistent with constriction. Pericardial thickening without calcification on computed-tomography chest. Proceeded to pericardiectomy.
February 2019	All diuretics ceased. Discharged from hospital.
May 2019	Anti-TB therapy ceased following completion of 36-week course.
June 2019	No residual heart failure symptoms at follow-up